Artisan Partners Portfolio holdings
AUM
$67.2B
1-Year Return
27.89%
This Quarter Return
+13.3%
1 Year Return
+27.89%
3 Year Return
+122.39%
5 Year Return
+197.97%
10 Year Return
+582.49%
AUM
$69.4B
AUM Growth
+$7.47B
(+12%)
Cap. Flow
+$833M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
19.05%
Holding
335
New
31
Increased
170
Reduced
106
Closed
26
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$371M |
| 2 |
Netflix
NFLX
|
$316M |
| 3 |
Boston Scientific
BSX
|
$264M |
| 4 |
Ascendis Pharma
ASND
|
$244M |
| 5 |
Atlassian
TEAM
|
$196M |
Top Sells
| 1 |
Zoom
ZM
|
$1.02B |
| 2 |
Oracle
ORCL
|
$622M |
| 3 |
Spotify
SPOT
|
$432M |
| 4 |
Microsoft
MSFT
|
$416M |
| 5 |
L3Harris
LHX
|
$284M |
Sector Composition
| 1 | Technology | 28.79% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 14.75% |
| 4 | Financials | 13.32% |
| 5 | Communication Services | 11.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORTX
276
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $15M | 0.02% |
365,156
+80,769
| +28% | +$3.32M |
|
|
RDUS
277
DELISTED
Radius Health, Inc.
RDUS
| $14.7M | 0.02% |
1,297,423
-68,094
| -5% | -$772K |
|
|
QTNT
278
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $13.9M | 0.02% |
67,393
+33,582
| +99% | +$6.9M |
|
279
uniQure
QURE
$973M
| $13.4M | 0.02% |
363,545
+26,087
| +8% | +$961K |
|
280
Vertex Pharmaceuticals
VRTX
$102B
| $12.4M | 0.02% |
+45,582
| New | +$12.4M |
|
|
HZNP
281
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.8M | 0.02% |
+152,259
| New | +$11.8M |
|
282
Agios Pharmaceuticals
AGIO
$2.1B
| $11.7M | 0.02% |
335,539
+73,958
| +28% | +$2.59M |
|
|
SUMO
283
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $11.1M | 0.02% |
+510,314
| New | +$11.1M |
|
|
TCDA
284
DELISTED
Tricida, Inc. Common Stock
TCDA
| $11M | 0.02% |
1,213,328
-30,895
| -2% | -$280K |
|
285
Compugen
CGEN
$132M
| $9.51M | 0.01% |
584,938
+124,322
| +27% | +$2.02M |
|
286
UroGen Pharma
URGN
$870M
| $8.89M | 0.01% |
460,970
+99,171
| +27% | +$1.91M |
|
287
Axalta
AXTA
$6.76B
| $7.63M | 0.01% |
344,260
-1,615,286
| -82% | -$35.8M |
|
288
Aprea Therapeutics
APRE
$8.74M
| $7M | 0.01% |
14,554
+2,935
| +25% | +$1.41M |
|
289
ICICI Bank
IBN
$114B
| $6.99M | 0.01% |
710,603
+25,033
| +4% | +$246K |
|
290
Globant
GLOB
$2.75B
| $6.04M | 0.01% |
33,705
+1,066
| +3% | +$191K |
|
291
Norfolk Southern
NSC
$62.8B
| $5.66M | 0.01% |
+26,455
| New | +$5.66M |
|
|
NOAH
292
Noah Holdings
NOAH
$819M
| $5.52M | 0.01% |
211,581
+13,415
| +7% | +$350K |
|
293
Protara Therapeutics
TARA
$122M
| $4.99M | 0.01% |
+296,384
| New | +$4.99M |
|
294
Bentley Systems
BSY
$16.3B
| $4.9M | 0.01% |
+155,986
| New | +$4.9M |
|
295
Credicorp
BAP
$20.6B
| $4.77M | 0.01% |
38,470
+1,255
| +3% | +$156K |
|
296
iQIYI
IQ
$2.61B
| $4.47M | 0.01% |
197,891
+12,036
| +6% | +$272K |
|
|
BZUN
297
Baozun
BZUN
$223M
| $4.38M | 0.01% |
134,896
+8,088
| +6% | +$263K |
|
|
ARCE
298
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $3.97M | 0.01% |
97,252
-1,349,577
| -93% | -$55.1M |
|
299
Copa Holdings
CPA
$4.86B
| $3.47M | ﹤0.01% |
68,822
+2,053
| +3% | +$103K |
|
300
Merus
MRUS
$5.01B
| $3.43M | ﹤0.01% |
286,175
+70,798
| +33% | +$850K |
|